{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 451555297
| IUPAC_name = 1-[2-(3-methylbutoxy)-2-phenylethyl]pyrrolidine
| image = Amixetrine.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 24622-72-8
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 71911
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 64922
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104080
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7UL287YTPJ

<!--Chemical data-->
| C=17 | H=27 | N=1 | O=1 
| molecular_weight = 261.40 g/mol
| smiles = O(CCC(C)C)C(c1ccccc1)CN2CCCC2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H27NO/c1-15(2)10-13-19-17(14-18-11-6-7-12-18)16-8-4-3-5-9-16/h3-5,8-9,15,17H,6-7,10-14H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ISRODTBNJUAWEJ-UHFFFAOYSA-N
}}

'''Amixetrine''' ([[International Nonproprietary Name|INN]]) (brand name '''Somagest'''; developmental code name '''CERM-898''') is a [[drug]] that was formerly marketed in [[France]] but is now no longer sold.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA80|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=80–}}</ref><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA285|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=285–}}</ref> According to various sources it has been said to be an [[anti-inflammatory]], [[antidepressant]], [[antispasmodic]], [[anticholinergic]], [[antihistamine]], and [[antiserotonergic]], but its definitive indications and pharmacology are unclear.<ref name="Elks2014" /><ref name="Publishing2013" /> The drug was first synthesized in 1969 and was introduced in France in 1972.<ref name="Elks2014" /><ref name="Publishing2013" />

==References==
{{reflist|30em}}

[[Category:Abandoned drugs]]
[[Category:Anti-inflammatory agents]]
[[Category:Antidepressants]]
[[Category:Antispasmodics]]
[[Category:Drugs with unknown mechanisms of action]]
[[Category:Ethers]]
[[Category:Pyrrolidines]]


{{musculoskeletal-drug-stub}}